RxDoctor Payments Data

David Rose, MD

Neurology · Tampa, FLNPI 1114174729

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,051,402 of the $1,447,030 with a category attached, or 72.7%. 24 manufacturers reported payments, led by CSL Behring at 32.2% of the total. Among neurology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,447,030in general payments, 2019–2025

Across 1,415 payments — averaging $1022.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$465K
  • Chiesi USA, Inc.$402K
  • Boston Scientific$315K
  • Atricure, Inc.$151K
  • Medtronic$77K
  • Viz.ai, Inc.$17K
  • plus $20K from 18 others
$31,781in research payments, 2019–2025

Across 13 payments — averaging $2444.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$22K
  • Boehringer Ingelheim$9K

What the payments were for

  • Consulting fees$196,33514%
  • Speaking & faculty fees$1,051,40273%
  • Travel & lodging$160,61311%
  • Food & beverage$38,6573%
  • Education$230%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,447,030 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Medicare billing

Part B allowed, 2024
$17,241
Medicare patients
89
Services billed
103

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Repatha SureclickEvolocumab14$7,882

Paid to pharmacies, not to this prescriber.

Other neurology in Tampa

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →